(Q37995597)

26 August 2017

1 reference

title

Clinical applications of 3'-azido-2',3'-dideoxythymidine (AZT) and related dideoxynucleosides (English)

1 reference

26 August 2017

Broder S

1

1 reference

26 August 2017

language of work or name

1 reference

1 October 1990

1 reference

Medicinal Research Reviews

26 August 2017

published in

1 reference

26 August 2017

volume

10

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

419-439

1 reference

Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610100403

Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3'-azido-2',3'-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610100403

Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610100403

Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610100403

Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610100403

Metabolism of acyclovir in virus-infected and uninfected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610100403

Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610100403

Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610100403

Treatment of human immunodeficiency virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610100403

Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610100403

Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610100403

Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610100403

Retrosternal pain is an early indicator of oxygen toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610100403

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

21 January 2018

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.6189183

Identifiers

DOI

10.1002/MED.2610100403

1 reference

26 August 2017

1 reference